MultiCell Signs License Agreement With Eisai Japan to Use Fa2N-4 …Therapeutics Daily (subscription) (press release), PA - Apr 24, 2007… April 24 /PRNewswire-FirstCall/ — MultiCell Technologies, Inc. (BULLETIN BOARD: MCET) , has executed a five year licensing agreement with Eisai Co., …
Read full story
MultiCell Signs License Agreement With Eisai Japan to Use Fa2N-4 …PharmaLive.com (press release), PA - Apr 24, 2007SAN DIEGO, April 24, 2007 /PRNewswire-FirstCall/ — MultiCell Technologies, Inc. , has executed a five year licensing agreement with Eisai Co., …MultiCell Signs License Agreement With Eisai Japan to Use Fa2N-4 … Therapeutics Daily (subscription) (press release)all 3 news articles
Read full story
MultiCell Signs License Agreement With Eisai Japan to Use Fa2N-4 …PR Newswire (press release), NY - Apr 24, 2007… has executed a five year licensing agreement with Eisai Co., Ltd. of Tokyo, Japan, one of the world's top 25 pharmaceutical companies. …
Read full story
MultiCell Signs License Agreement With Eisai Japan to Use Fa2N-4 …PR-Inside.com (Pressemitteilung), Austria - Apr 24, 2007… April 24 /PRNewswire-FirstCall/ — MultiCell Technologies, Inc. (BULLETIN BOARD: MCET) , has executed a five year licensing agreement with Eisai Co., …
Read full story
A relative of anti-aging gene Klotho also influences metabolic …innovations report, Germany - 3 hours agoThe Eisai Research Fund, Ellison Medical Foundation, Ted Nash Long Life Foundation, Irma T. Hirschl Fund and the National Institutes of Health supported the …
Read full story
Japan investors see food, drug firms as M&A targetsEconomic Times, India - 9 hours ago… Nissin Food Products Co Ltd, Sapporo Holdings Ltd, Takeda Pharmaceutical Co Ltd and Eisai Co Ltd were seen by respondents as likely takeover targets. …
Read full story
Research and Markets: Eisai Has an Estimated Market Potential of …PharmaLive.com (press release), PA - 9 hours agoEisai is co-developing Abbott's adalimumab (marketed as Humira) for markets in Japan, Thailand and Korea. Currently it is one of Abbott's highest selling …
Read full story
MultiCell Signs License Agreement With Eisai Japan to Use Fa2N-4 …Earthtimes.org - 1 hour agoSAN DIEGO, April 24 — MultiCell Technologies, Inc. (BULLETIN BOARD: MCET) , has executed a five year licensing agreement with Eisai Co., Ltd. of Tokyo, …MultiCell Signs License Agreement With Eisai Japan to Use Fa2N-4 … PharmaLive.com (press release)MultiCell Signs License Agreement With Eisai Japan to Use Fa2N-4 … PR Newswire (press release)MultiCell Signs License Agreement With Eisai Japan to Use Fa2N-4 … PR-Inside.com (Pressemitteilung)all 4 news articles
Read full story
Research and Markets: Eisai Has an Estimated Market Potential of …Business Wire (press release), CA - 38 minutes agoEisai is co-developing Abbott’s adalimumab (marketed as Humira) for markets in Japan, Thailand and Korea. Currently it is one of Abbott’s highest selling …
Read full story
Citigroup May Fail to Secure Full Control Over Nikko CordialBloomberg - 9 hours agoEisai Co., Japan's fourth-largest drugmaker with 0.49 percent, has also accepted the offer. Fujifilm Holdings Corp., which has 0.11 percent, …
Read full story
Science Daily (press release)Obesity May Be Associated With A Relative Of Anti-aging Gene, KlothoScience Daily (press release) - 9 hours agoThe Eisai Research Fund, Ellison Medical Foundation, Ted Nash Long Life Foundation, Irma T. Hirschl Fund and the National Institutes of Health supported the …
Read full story
A relative of anti-aging gene Klotho also influences metabolic …EurekAlert (press release), DC - 4 hours agoThe Eisai Research Fund, Ellison Medical Foundation, Ted Nash Long Life Foundation, Irma T. Hirschl Fund and the National Institutes of Health supported the …
Read full story
Takeda, Eisai Takeovers Raise Biotech Costs for Merck, NovartisBloomberg - Apr 18, 2007Takeda Pharmaceutical Co. and Eisai Co. spent $500 million last month for acquisitions, almost five times as much as all Japanese companies paid in the two …
Read full story
Eisai Unveils Completion Of Acquisition Of Morphotek - Quick FactsTrading Markets, CA - Apr 16, 2007(RTTNews) - Tuesday, Eisai Corporation of North America, a wholly-owned subsidiary of Tokyo-based Eisai Co., Ltd., (ESALF.PK) revealed the completion of …
Read full story
Eisai Announces Completion of Acquisition of MorphotekPR Newswire (press release), NY - Apr 16, 2007About Eisai Corporation of North America Eisai Corporation of North America is a wholly owned subsidiary of Eisai Co., Ltd. and supports the activities of …
Read full story
Eisai Announces Completion of Acquisition of MorphotekChemie.de (press release), Germany - Apr 17, 200718 Apr 2007 - Eisai Co., Ltd. and Eisai Corporation of North America announced the completion of Eisai's acquisition of Morphotek® Inc. after having cleared …
Read full story
Takeda, Eisai Raise Biotech Costs for Merck, Novartis (Update2)Bloomberg - 6 hours agoTakeda Pharmaceutical Co. and Eisai Co. spent $500 million last month for acquisitions, almost five times as much as all Japanese companies paid in the two …
Read full story
A Once-weekly Formulation of Risedronate Sodium Hydrate, an …PipelineReview.com (press release), Spain - 11 hours agoBoth Ajinomoto and Takeda own the drug manufacturing approval of above products while Eisai Co., Ltd. ("Eisai", President and CEO: Haruo Naito, …
Read full story
A Once-weekly Formulation of Risedronate Sodium Hydrate, an …Japan Corporate News (press release), Japan - 3 hours agoBoth Ajinomoto and Takeda own the drug manufacturing approval of above products while Eisai Co., Ltd. ("Eisai", President and CEO: Haruo Naito, …
Read full story
Eisai Announces Completion of Acquisition of MorphotekPharmaLive.com (press release), PA - 11 hours agoEisai Corporation of North America is a wholly owned subsidiary of Eisai Co., Ltd. and supports the activities of its operating companies in North America. …Eisai Announces Completion of Acquisition of Morphotek Japan Corporate News (press release)Eisai Announces Completion of Acquisition of Morphotek PR Newswire (press release)all 9 news articles
Read full story